Part 5 · Living with MS
Nursing care
What drug labels, guidelines and nursing studies report on MS nursing care: assessment scales, infusion and first-dose monitoring, lab calendars, teaching and notes. Each part has an animation or a tool to try.
ScopeThis module reports what labels, guidelines and published studies say. It is not a care plan and does not replace local protocols, your scope of practice or the prescriber. Drug details come from current US labels unless stated. Where the sources name a gap, the module says so instead of filling it.
1 · Assessment
A head-to-toe screen, domain by domain
MS can touch almost every body system. Press play to walk through the domains the guidelines and nursing literature name, with how common each problem is and the tool used to look for it.
Body outline schematic. Bars and dots are drawn to the published figures; the falls grid scales 537 people to 100.
Scored measures: try the numbers
Enter a baseline and a follow-up value to see how the change compares with the threshold the literature uses. These are teaching tools with made-up starting values, not a clinical record.
The other scales, and what could not be confirmed
2 · Infusions and first doses
An ocrelizumab infusion day
Premedication, a stepped infusion rate, and observation afterwards. Switch to the comparison to see how the observation rule differs from drug to drug. You can also add an infusion reaction to see what the label says happens to the rate.
Rates and timings from the current US label; the time axis is compressed before the start and after the infusion.
Fingolimod: the first-dose observation
The first dose of fingolimod slows the heart. The label describes six hours of observation and when it is extended. Choose a course to see the decision at hour 6.
The heart-rate line is a schematic shape with no scale; the 45 bpm line marks the label's adult threshold, not a measured value.
Self-injected medicines
3 · The monitoring calendar
Each disease-modifying therapy brings its own schedule of blood tests, examinations and repeat checks. Press play to run four years and see which checks recur for which drug. The anti-JCV toggle shows a real difference between US and European guidance.
Schedules as the current US labels describe them, placed on a calendar for teaching. Real dates depend on start dates, delays and local protocols.
4 · High-dose methylprednisolone for relapse
NICE makes oral methylprednisolone the default for a relapse, with IV as an alternative. The label and the trials describe what to watch for. The tool below checks an IV regimen against the one rate the label singles out.
5 · Teaching, and what gets misunderstood
Relapse or not? The NICE definition as a sorter
A worse day is not always a relapse. Answer the questions to see how NICE's definition sorts a change in symptoms.
Common misunderstandings
Each belief is set against what a source says. Open one to read it.
Teaching topics the guidelines and labels name
6 · Documentation
No MS-specific nursing documentation standard, from IOMSN or any nursing body, could be found and validated for this module. The checklist below is built from the NICE comprehensive-review content and from label monitoring requirements instead. 352
Entry outline built from what you ticked
A worked outline of the items the sources list. Your service decides the format.
7 · The MS nurse and the team
People with MS per whole-time MS specialist nurse, UK
Bars to scale. Figures from the MS Trust 2021 mapping survey and Punshon et al. 2021. 332,392